TriMas Reports Third Quarter 2021 Results
Delivered Solid Sales and Earnings Growth; Recently Initiated Dividend Program
TriMas Highlights
-
Increased third quarter net sales by 11.5%, with record third quarter sales in
TriMas' Packaging segment - Leveraged increased sales to nearly double year-over-year operating profit in the Specialty Products segment
-
Reported diluted EPS of
$0.45 , while adjusted diluted EPS(1) increased by 9.6% to$0.57 - Added quarterly dividend program to the Company's balanced, long-term capital allocation strategy
- Raised full year 2021 Free Cash Flow(2) outlook and reaffirmed 2021 sales and adjusted diluted EPS(1) outlook midpoints
Third Quarter 2021
TriMas reported third quarter 2021 net sales of
The Company reported third quarter 2021 net income of
"Overall, we are pleased with our third quarter results and our continued positive momentum," said
"Our solid execution in the quarter was complemented by our balanced approach to capital allocation and disciplined management of our balance sheet. Last week, we were excited to announce the initiation of a dividend program, and believe our capital structure enables us to continue to invest in organic growth initiatives and strategic acquisitions, while also returning capital to shareholders through share repurchases and now dividends. We believe our focus on maintaining a strong balance sheet, coupled with consistent cash generation, is a sound formula to deliver long-term value to our shareholders.
"While there are still continued macro uncertainties and input cost pressures, we continue to proactively manage our businesses, leveraging the TriMas Business Model. As a result, we are raising our full year 2021 Free Cash Flow(2) outlook and reaffirming our full year 2021 sales and EPS outlook midpoints, while also tightening the ranges. We now anticipate full year 2021 sales growth of 10% to 13% compared to 2020, and adjusted EPS(1) to range between
Financial Position
The Company reported net cash provided by operating activities of
On
In addition, during the third quarter of 2021, the Company repurchased 129,866 shares of its outstanding common stock for approximately
TriMas ended third quarter 2021 with
Third Quarter Segment Results
TriMas operates in three segments: Packaging, Aerospace and Specialty Products. With its diversified portfolio of businesses, each of which go to market with well-recognized brand names in the markets they serve, TriMas predominantly participates in the consumer products, aerospace & defense, and industrial markets. Its largest segment is Packaging, generating approximately two-thirds of TriMas' overall sales, followed by the Aerospace and Specialty Products segments, which comprise of approximately 21% and 15% of total sales, respectively.
Packaging (Approximately 64% of TriMas
Aerospace (Approximately 21% of TriMas
Specialty Products (Approximately 15% of TriMas
TriMas' Specialty Products segment, which includes the Norris Cylinder™ and Arrow® Engine brands, designs, manufactures and distributes highly-engineered steel cylinders, as well as wellhead products, for use within the welding and HVAC, military, industrial, and oil and gas end markets. Norris Cylinder, which has recently been designated a "Made in the
Outlook
The Company raised its 2021 Free Cash Flow(2) outlook and reaffirmed its full year 2021 sales and earnings outlook midpoints, while tightening the ranges previously provided on its second quarter earnings call. The Company is now estimating that TriMas’ 2021 consolidated sales growth will range between 10% to 13%, as compared to full year 2020, and as compared to the previously provided sales growth range of 9% to 14%. The Company now expects full year 2021 adjusted diluted earnings per share(1) to be in the range of
"During the third quarter, we continued to see increasing input costs, primarily resin, steel and freight, and we continued to operate in a constrained labor environment. We anticipate that we will be able to offset these challenges, and therefore, are reaffirming our outlook midpoints. We are pleased to expect full year 2021 sales growth in all three segments and an EPS range representing an increase of approximately 16% at the midpoint, as compared to 2020, especially in light of the continued macro uncertainties," added Amato.
All of the above amounts considered as 2021 guidance are after adjusting for any current or future amounts that may be considered Special Items, and in the case of adjusted diluted earnings per share, acquisition-related intangible asset amortization expense for deals that have not yet been consummated. The inability to predict the amount and timing of the impacts of these Special Items makes a detailed reconciliation of these forward-looking non-GAAP financial measures impracticable.(1)
Conference Call Information
TriMas will host its third quarter 2021 earnings conference call today,
Notice Regarding Forward-Looking Statements
Any "forward-looking" statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, contained herein, including those relating to TriMas’ business, financial condition or future results, involve risks and uncertainties with respect to, including, but not limited to: the severity and duration of the ongoing coronavirus (“COVID-19”) pandemic on our operations, customers and suppliers, as well as related actions taken by governmental authorities and other third parties in response, each of which is uncertain, rapidly changing and difficult to predict; general economic and currency conditions; material and energy costs; risks and uncertainties associated with intangible assets, including goodwill or other intangible asset impairment charges; competitive factors; future trends; our ability to realize our business strategies; our ability to identify attractive acquisition candidates, successfully integrate acquired operations or realize the intended benefits of such acquisitions; information technology and other cyber-related risks; the performance of our subcontractors and suppliers; supply constraints, including the availability and cost of raw materials; market demand; intellectual property factors; litigation; government and regulatory actions, including, without limitation, climate change legislation and other environmental regulations, as well as the impact of tariffs, quotas and surcharges; our leverage; liabilities imposed by our debt instruments; labor disputes; changes to fiscal and tax policies; contingent liabilities relating to acquisition activities; the disruption of operations from catastrophic or extraordinary events, including natural disasters and public health crises; the potential impact of Brexit; our future prospects; and other risks that are detailed in the Company's Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
In this release, certain non-GAAP financial measures are used. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measure may be found in Appendix I at the end of this release. Management believes that presenting these non-GAAP financial measures provides useful information to investors by helping them identify underlying trends in the Company’s businesses and facilitating comparisons of performance with prior and future periods and to the Company’s peers. These non-GAAP financial measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.
Reconciliations of forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures are provided only for the expected impact of amortization of acquisition-related intangible assets for completed acquisitions, as the Company is unable to provide estimates of future Special Items(1) or amortization from future acquisitions without unreasonable effort, due to the uncertainty and inherent difficulty of predicting the occurrence and the financial impact of such items impacting comparability and the periods in which such items may be recognized. For the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.
Additional information is available at www.trimascorp.com under the “Investors” section.
|
(1) |
The Company defines adjusted diluted earnings per share as net income (per GAAP), plus or minus the after-tax impact of Special Items(2), plus the after-tax impact of non-cash acquisition-related intangible asset amortization expense. While the acquisition-related intangible assets aid in the Company’s revenue generation, the Company adjusts for the non-cash amortization expense because the Company believes it (i) enhances management’s and investors’ ability to analyze underlying business performance, (ii) facilitates comparisons of financial results over multiple periods, and (iii) provides more relevant comparisons of financial results with the results of other companies as the amortization expense associated with these assets may fluctuate significantly from period to period based on the timing, size, nature, and number of acquisitions. |
|
|
(2) |
The Company defines Free Cash Flow as Net Cash Provided by/Used for Operating Activities, excluding the cash impact of Special Items, less Capital Expenditures. Please see Appendix I for additional details. |
|
|
(3) |
Appendix I details certain costs, expenses and other amounts or charges, collectively described as "Special Items," that are included in the determination of net income, earnings per share and/or cash flows from operating activities under GAAP, but that management believes should be separately considered when evaluating the quality of the Company’s core operating results, given they may not reflect the ongoing activities of the business. |
About TriMas
TriMas is a global manufacturer and provider of products for customers primarily in the consumer products, aerospace and industrial end markets, with approximately 3,300 dedicated employees in 11 countries. We provide customers with a wide range of innovative and quality product solutions through our market-leading businesses. Our TriMas family of businesses has strong brand names in the end markets served, and operates under a common set of values and strategic priorities under the TriMas Business Model. TriMas is publicly traded on the NASDAQ under the ticker symbol “TRS,” and is headquartered in
|
|
||||||||
|
Condensed Consolidated Balance Sheet |
||||||||
|
(Dollars in thousands) |
||||||||
|
|
|
|
|
|
||||
|
2021 |
2020 |
|||||||
|
Assets |
|
(unaudited) |
|
|
||||
|
Current assets: |
|
|
|
|
||||
|
Cash and cash equivalents |
|
$ |
136,960 |
|
|
$ |
73,950 |
|
|
Receivables, net |
|
135,010 |
|
|
113,410 |
|
||
|
Inventories |
|
154,330 |
|
|
149,380 |
|
||
|
Prepaid expenses and other current assets |
|
17,070 |
|
|
15,090 |
|
||
|
Total current assets |
|
443,370 |
|
|
351,830 |
|
||
|
Property and equipment, net |
|
254,330 |
|
|
253,060 |
|
||
|
Operating lease right-of-use assets |
|
37,360 |
|
|
37,820 |
|
||
|
|
|
299,040 |
|
|
303,970 |
|
||
|
Other intangibles, net |
|
187,770 |
|
|
206,200 |
|
||
|
Deferred income taxes |
|
9,190 |
|
|
19,580 |
|
||
|
Other assets |
|
27,200 |
|
|
21,420 |
|
||
|
Total assets |
|
$ |
1,258,260 |
|
|
$ |
1,193,880 |
|
|
Liabilities and Shareholders' Equity |
|
|
|
|
||||
|
Current liabilities: |
|
|
|
|
||||
|
Accounts payable |
|
$ |
71,990 |
|
|
$ |
69,910 |
|
|
Accrued liabilities |
|
59,820 |
|
|
60,540 |
|
||
|
Operating lease liabilities, current portion |
|
6,600 |
|
|
6,740 |
|
||
|
Total current liabilities |
|
138,410 |
|
|
137,190 |
|
||
|
Long-term debt, net |
|
393,600 |
|
|
346,290 |
|
||
|
Operating lease liabilities |
|
31,860 |
|
|
31,610 |
|
||
|
Deferred income taxes |
|
19,250 |
|
|
24,850 |
|
||
|
Other long-term liabilities |
|
60,820 |
|
|
69,690 |
|
||
|
Total liabilities |
|
643,940 |
|
|
609,630 |
|
||
|
Total shareholders' equity |
|
614,320 |
|
|
584,250 |
|
||
|
Total liabilities and shareholders' equity |
|
$ |
1,258,260 |
|
|
$ |
1,193,880 |
|
|
|
||||||||||||||||
|
Consolidated Statement of Operations |
||||||||||||||||
|
(Unaudited - dollars in thousands, except per share amounts) |
||||||||||||||||
|
|
|
Three months ended |
|
Nine months ended |
||||||||||||
|
|
|
|
||||||||||||||
|
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
|
Net sales |
|
$ |
222,420 |
|
|
$ |
199,460 |
|
|
$ |
648,140 |
|
|
$ |
581,800 |
|
|
Cost of sales |
|
|
(163,980 |
) |
|
|
(147,530 |
) |
|
|
(480,340 |
) |
|
|
(446,270 |
) |
|
Gross profit |
|
|
58,440 |
|
|
|
51,930 |
|
|
|
167,800 |
|
|
|
135,530 |
|
|
Selling, general and administrative expenses |
|
|
(27,620 |
) |
|
|
(25,650 |
) |
|
|
(90,300 |
) |
|
|
(107,570 |
) |
|
Impairment of goodwill and indefinite-lived intangible assets |
|
|
— |
|
|
|
(134,600 |
) |
|
|
— |
|
|
|
(134,600 |
) |
|
Operating profit (loss) |
|
|
30,820 |
|
|
|
(108,320 |
) |
|
|
77,500 |
|
|
|
(106,640 |
) |
|
Other expense, net: |
|
|
|
|
|
|
|
|
||||||||
|
Interest expense |
|
|
(3,440 |
) |
|
|
(3,450 |
) |
|
|
(11,110 |
) |
|
|
(11,260 |
) |
|
Debt financing and related expenses |
|
|
— |
|
|
|
— |
|
|
|
(10,520 |
) |
|
|
— |
|
|
Other income (expense), net |
|
|
(540 |
) |
|
|
(1,200 |
) |
|
|
(800 |
) |
|
|
(150 |
) |
|
Other expense, net |
|
|
(3,980 |
) |
|
|
(4,650 |
) |
|
|
(22,430 |
) |
|
|
(11,410 |
) |
|
Income (loss) before income tax expense |
|
|
26,840 |
|
|
|
(112,970 |
) |
|
|
55,070 |
|
|
|
(118,050 |
) |
|
Income tax benefit (expense) |
|
|
(7,250 |
) |
|
|
12,100 |
|
|
|
(10,580 |
) |
|
|
14,600 |
|
|
Net income (loss) |
|
$ |
19,590 |
|
|
$ |
(100,870 |
) |
|
$ |
44,490 |
|
|
$ |
(103,450 |
) |
|
Basic earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
|
Net income (loss) per share |
|
$ |
0.46 |
|
|
$ |
(2.32 |
) |
|
$ |
1.03 |
|
|
$ |
(2.37 |
) |
|
Weighted average common shares—basic |
|
|
42,889,922 |
|
|
|
43,457,704 |
|
|
|
43,061,707 |
|
|
|
43,707,331 |
|
|
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
|
Net income (loss) per share |
|
$ |
0.45 |
|
|
$ |
(2.32 |
) |
|
$ |
1.03 |
|
|
$ |
(2.37 |
) |
|
Weighted average common shares—diluted |
|
|
43,094,099 |
|
|
|
43,457,704 |
|
|
|
43,345,777 |
|
|
|
43,707,331 |
|
|
|
||||||||
|
Consolidated Statement of Cash Flow |
||||||||
|
(Unaudited - dollars in thousands) |
||||||||
|
|
|
Nine months ended |
||||||
|
|
||||||||
|
|
|
2021 |
|
2020 |
||||
|
Cash Flows from Operating Activities: |
|
|
|
|
||||
|
Net income (loss) |
|
$ |
44,490 |
|
|
$ |
(103,450 |
) |
|
Adjustments to reconcile net income to net cash provided by operating activities, net of acquisition impact: |
|
|
|
|
||||
|
Impairment of goodwill and indefinite-lived intangible assets |
|
|
— |
|
|
|
134,600 |
|
|
Loss on dispositions of assets |
|
|
130 |
|
|
|
1,080 |
|
|
Depreciation |
|
|
23,740 |
|
|
|
21,700 |
|
|
Amortization of intangible assets |
|
|
16,150 |
|
|
|
15,460 |
|
|
Amortization of debt issue costs |
|
|
740 |
|
|
|
860 |
|
|
Deferred income taxes |
|
|
3,480 |
|
|
|
(17,790 |
) |
|
Non-cash compensation expense |
|
|
7,320 |
|
|
|
5,610 |
|
|
Debt financing and related expenses |
|
|
10,520 |
|
|
|
— |
|
|
Non-cash change in legacy liability estimate |
|
|
— |
|
|
|
23,400 |
|
|
Increase in receivables |
|
|
(23,260 |
) |
|
|
(6,210 |
) |
|
(Increase) decrease in inventories |
|
|
(5,850 |
) |
|
|
4,510 |
|
|
(Increase) decrease in prepaid expenses and other assets |
|
|
(3,830 |
) |
|
|
5,500 |
|
|
Increase (decrease) in accounts payable and accrued liabilities |
|
|
450 |
|
|
|
(7,410 |
) |
|
Other operating activities |
|
|
3,660 |
|
|
|
1,250 |
|
|
Net cash provided by operating activities, net of acquisition impact |
|
|
77,740 |
|
|
|
79,110 |
|
|
Cash Flows from Investing Activities: |
|
|
|
|
||||
|
Capital expenditures |
|
|
(29,850 |
) |
|
|
(17,670 |
) |
|
Acquisition of businesses, net of cash acquired |
|
|
— |
|
|
|
(95,160 |
) |
|
Net proceeds from disposition of business, property and equipment |
|
|
160 |
|
|
|
1,930 |
|
|
Net cash used for investing activities |
|
|
(29,690 |
) |
|
|
(110,900 |
) |
|
Cash Flows from Financing Activities: |
|
|
|
|
||||
|
Retirement of senior notes |
|
|
(300,000 |
) |
|
|
— |
|
|
Proceeds from issuance of senior notes |
|
|
400,000 |
|
|
|
— |
|
|
Proceeds from borrowings on revolving credit facilities |
|
|
— |
|
|
|
300,950 |
|
|
Repayments of borrowings on revolving credit facilities |
|
|
(48,620 |
) |
|
|
(303,240 |
) |
|
Debt financing fees and senior notes redemption premium |
|
|
(13,570 |
) |
|
|
— |
|
|
Shares surrendered upon exercise and vesting of equity awards to cover taxes |
|
|
(4,690 |
) |
|
|
(2,600 |
) |
|
Payments to purchase common stock |
|
|
(18,160 |
) |
|
|
(36,050 |
) |
|
Net cash provided by (used for) financing activities |
|
|
14,960 |
|
|
|
(40,940 |
) |
|
Cash and Cash Equivalents: |
|
|
|
|
||||
|
Increase (decrease) for the period |
|
|
63,010 |
|
|
|
(72,730 |
) |
|
At beginning of period |
|
|
73,950 |
|
|
|
172,470 |
|
|
At end of period |
|
$ |
136,960 |
|
|
$ |
99,740 |
|
|
Supplemental disclosure of cash flow information: |
|
|
|
|
||||
|
Cash paid for interest |
|
$ |
6,490 |
|
|
$ |
7,490 |
|
|
Cash paid for taxes |
|
$ |
8,250 |
|
|
$ |
6,660 |
|
Appendix I
|
|
||||||||||||||||
|
Additional Information Regarding Special Items Impacting |
||||||||||||||||
|
Reported GAAP Financial Measures |
||||||||||||||||
|
(Unaudited - dollars in thousands) |
||||||||||||||||
|
|
|
Three months ended |
|
Nine months ended |
||||||||||||
|
|
|
|||||||||||||||
|
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
|
Packaging |
|
|
|
|
|
|
|
|
||||||||
|
Net sales |
|
$ |
138,010 |
|
|
$ |
135,120 |
|
|
$ |
409,730 |
|
|
$ |
364,000 |
|
|
Operating profit |
|
$ |
27,340 |
|
|
$ |
28,020 |
|
|
$ |
76,490 |
|
|
$ |
70,340 |
|
|
Special Items to consider in evaluating operating profit: |
|
|
|
|
|
|
|
|
||||||||
|
Purchase accounting costs |
|
|
— |
|
|
|
— |
|
|
|
830 |
|
|
|
750 |
|
|
Business restructuring and severance costs |
|
|
— |
|
|
|
— |
|
|
|
1,900 |
|
|
|
2,730 |
|
|
Adjusted operating profit |
|
$ |
27,340 |
|
|
$ |
28,020 |
|
|
$ |
79,220 |
|
|
$ |
73,820 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Aerospace |
|
|
|
|
|
|
|
|
||||||||
|
Net sales |
|
$ |
46,510 |
|
|
$ |
39,130 |
|
|
$ |
135,680 |
|
|
$ |
130,660 |
|
|
Operating profit (loss) |
|
$ |
3,980 |
|
|
$ |
(133,500 |
) |
|
$ |
10,600 |
|
|
$ |
(132,630 |
) |
|
Special Items to consider in evaluating operating profit: |
|
|
|
|
|
|
|
|
||||||||
|
Impairment of goodwill and indefinite-lived intangible assets |
|
|
— |
|
|
|
134,600 |
|
|
|
— |
|
|
|
134,600 |
|
|
Pre-acquisition contingent liability |
|
|
— |
|
|
|
2,000 |
|
|
|
— |
|
|
|
2,000 |
|
|
Purchase accounting costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,030 |
|
|
Business restructuring and severance costs |
|
|
580 |
|
|
|
600 |
|
|
|
1,650 |
|
|
|
8,110 |
|
|
Adjusted operating profit |
|
$ |
4,560 |
|
|
$ |
3,700 |
|
|
$ |
12,250 |
|
|
$ |
14,110 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Specialty Products |
|
|
|
|
|
|
|
|
||||||||
|
Net sales |
|
$ |
37,900 |
|
|
$ |
25,210 |
|
|
$ |
102,730 |
|
|
$ |
87,140 |
|
|
Operating profit |
|
$ |
6,660 |
|
|
$ |
3,380 |
|
|
$ |
17,190 |
|
|
$ |
870 |
|
|
Special Items to consider in evaluating operating profit: |
|
|
|
|
|
|
|
|
||||||||
|
Business restructuring and severance costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
9,700 |
|
|
Adjusted operating profit |
|
$ |
6,660 |
|
|
$ |
3,380 |
|
|
$ |
17,190 |
|
|
$ |
10,570 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Corporate Expenses |
|
|
|
|
|
|
|
|
||||||||
|
Operating loss |
|
$ |
(7,160 |
) |
|
$ |
(6,220 |
) |
|
$ |
(26,780 |
) |
|
$ |
(45,220 |
) |
|
Special Items to consider in evaluating operating loss: |
|
|
|
|
|
|
|
|
||||||||
|
Change in accounting policy for asbestos-related costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
23,400 |
|
|
M&A diligence and transaction costs |
|
|
170 |
|
|
|
710 |
|
|
|
830 |
|
|
|
1,780 |
|
|
Business restructuring and severance costs |
|
|
40 |
|
|
|
— |
|
|
|
5,520 |
|
|
|
640 |
|
|
Adjusted operating loss |
|
$ |
(6,950 |
) |
|
$ |
(5,510 |
) |
|
$ |
(20,430 |
) |
|
$ |
(19,400 |
) |
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net sales |
|
$ |
222,420 |
|
|
$ |
199,460 |
|
|
$ |
648,140 |
|
|
$ |
581,800 |
|
|
Operating profit (loss) |
|
$ |
30,820 |
|
|
$ |
(108,320 |
) |
|
$ |
77,500 |
|
|
$ |
(106,640 |
) |
|
Total Special Items to consider in evaluating operating profit |
|
|
790 |
|
|
|
137,910 |
|
|
|
10,730 |
|
|
|
185,740 |
|
|
Adjusted operating profit |
|
$ |
31,610 |
|
|
$ |
29,590 |
|
|
$ |
88,230 |
|
|
$ |
79,100 |
|
Appendix I
|
|
||||||||||||||||
|
Additional Information Regarding Special Items Impacting |
||||||||||||||||
|
Reported GAAP Financial Measures |
||||||||||||||||
|
(Unaudited - dollars in thousands, except per share amounts) |
||||||||||||||||
|
|
|
Three months ended |
|
Nine months ended |
||||||||||||
|
|
|
|||||||||||||||
|
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
|
Net income (loss), as reported |
|
$ |
19,590 |
|
|
$ |
(100,870 |
) |
|
$ |
44,490 |
|
|
$ |
(103,450 |
) |
|
Special Items to consider in evaluating quality of net income (loss): |
|
|
|
|
|
|
|
|
||||||||
|
Impairment of goodwill and indefinite-lived intangible assets |
|
|
— |
|
|
|
134,600 |
|
|
|
— |
|
|
|
134,600 |
|
|
Change in accounting policy for asbestos-related costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
23,400 |
|
|
Business restructuring and severance costs |
|
|
620 |
|
|
|
600 |
|
|
|
9,680 |
|
|
|
21,180 |
|
|
Purchase accounting costs |
|
|
— |
|
|
|
— |
|
|
|
830 |
|
|
|
2,780 |
|
|
M&A diligence and transaction costs |
|
|
170 |
|
|
|
710 |
|
|
|
830 |
|
|
|
2,080 |
|
|
Pre-acquisition contingent liability |
|
|
— |
|
|
|
2,000 |
|
|
|
— |
|
|
|
2,000 |
|
|
Debt financing and related expenses |
|
|
— |
|
|
|
— |
|
|
|
10,520 |
|
|
|
— |
|
|
Income tax effect of Special Items(1) |
|
|
80 |
|
|
|
(18,400 |
) |
|
|
(5,830 |
) |
|
|
(30,190 |
) |
|
Adjusted net income |
|
$ |
20,460 |
|
|
$ |
18,640 |
|
|
$ |
60,520 |
|
|
$ |
52,400 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
Three months ended |
|
Nine months ended |
||||||||||||
|
|
|
|||||||||||||||
|
|
|
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
Diluted earnings (loss) per share, as reported |
|
$ |
0.45 |
|
|
$ |
(2.32 |
) |
|
$ |
1.03 |
|
|
$ |
(2.37 |
) |
|
Dilutive impact (2) |
|
|
— |
|
|
|
0.01 |
|
|
|
— |
|
|
|
0.01 |
|
|
Special Items to consider in evaluating quality of EPS: |
|
|
|
|
|
|
|
|
||||||||
|
Impairment of goodwill and indefinite-lived intangible assets |
|
|
— |
|
|
|
3.08 |
|
|
|
— |
|
|
|
3.07 |
|
|
Change in accounting policy for asbestos-related costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.53 |
|
|
Business restructuring and severance costs |
|
|
0.02 |
|
|
|
0.01 |
|
|
|
0.22 |
|
|
|
0.48 |
|
|
Purchase accounting costs |
|
|
— |
|
|
|
— |
|
|
|
0.02 |
|
|
|
0.06 |
|
|
M&A diligence and transaction costs |
|
|
0.01 |
|
|
|
0.02 |
|
|
|
0.02 |
|
|
|
0.05 |
|
|
Pre-acquisition contingent liability |
|
|
— |
|
|
|
0.05 |
|
|
|
— |
|
|
|
0.05 |
|
|
Debt financing and related expenses |
|
|
— |
|
|
|
— |
|
|
|
0.24 |
|
|
|
— |
|
|
Income tax effect of Special Items(1) |
|
|
— |
|
|
|
(0.42 |
) |
|
|
(0.13 |
) |
|
|
(0.69 |
) |
|
Pre-tax amortization of acquisition-related intangible assets |
|
|
0.12 |
|
|
|
0.12 |
|
|
|
0.37 |
|
|
|
0.35 |
|
|
Income tax benefit on amortization of acquisition-related intangible assets(1) |
|
|
(0.03 |
) |
|
|
(0.03 |
) |
|
|
(0.09 |
) |
|
|
(0.09 |
) |
|
Adjusted diluted EPS |
|
$ |
0.57 |
|
|
$ |
0.52 |
|
|
$ |
1.68 |
|
|
$ |
1.45 |
|
|
Weighted-average shares outstanding(2) |
|
|
43,094,099 |
|
|
|
43,672,026 |
|
|
|
43,345,777 |
|
|
|
43,930,237 |
|
|
(1) |
Income tax effect of Special Items and amortization of acquisition-related intangible assets is calculated on an item-by-item basis, utilizing the tax rate in the jurisdiction where the Special Item or amortization occurred. For the three and nine month periods ended |
|
|
(2) |
214,322 and 222,906 shares for the three and nine months ended |
Appendix I
|
|
||||||||||||||||||||||
|
Additional Information Regarding Special Items Impacting |
||||||||||||||||||||||
|
Reported GAAP Financial Measures |
||||||||||||||||||||||
|
(Unaudited - dollars in thousands) |
||||||||||||||||||||||
|
|
|
Three months ended |
||||||||||||||||||||
|
|
|
2021 |
|
2020 |
||||||||||||||||||
|
|
|
As reported |
|
Special
|
|
As
|
|
As
|
|
Special
|
|
As
|
||||||||||
|
Net cash provided by operating activities |
|
$ |
35,070 |
|
|
$ |
1,180 |
|
$ |
36,250 |
|
|
$ |
48,270 |
|
|
$ |
1,740 |
|
$ |
50,010 |
|
|
Less: Capital expenditures |
|
|
(11,520 |
) |
|
|
— |
|
|
(11,520 |
) |
|
|
(8,420 |
) |
|
|
— |
|
|
(8,420 |
) |
|
Free Cash Flow |
|
|
23,550 |
|
|
|
1,180 |
|
|
24,730 |
|
|
|
39,850 |
|
|
|
1,740 |
|
|
41,590 |
|
|
Net income (loss) |
|
|
19,590 |
|
|
|
870 |
|
|
20,460 |
|
|
|
(100,870 |
) |
|
|
119,510 |
|
|
18,640 |
|
|
Free Cash Flow as a percentage of net income |
|
|
120 |
% |
|
|
|
|
121 |
% |
|
|
NM |
|
|
|
|
|
223 |
% |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
Nine months ended |
||||||||||||||||||||
|
|
|
2021 |
|
2020 |
||||||||||||||||||
|
|
|
As reported |
|
Special
|
|
As
|
|
As
|
|
Special
|
|
As
|
||||||||||
|
Net cash provided by operating activities |
|
$ |
77,740 |
|
|
$ |
7,770 |
|
$ |
85,510 |
|
|
$ |
79,110 |
|
|
$ |
7,100 |
|
$ |
86,210 |
|
|
Less: Capital expenditures |
|
|
(29,850 |
) |
|
|
— |
|
|
(29,850 |
) |
|
|
(17,670 |
) |
|
|
— |
|
|
(17,670 |
) |
|
Free Cash Flow |
|
|
47,890 |
|
|
|
7,770 |
|
|
55,660 |
|
|
|
61,440 |
|
|
|
7,100 |
|
|
68,540 |
|
|
Net income (loss) |
|
|
44,490 |
|
|
|
16,030 |
|
|
60,520 |
|
|
|
(103,450 |
) |
|
|
155,850 |
|
|
52,400 |
|
|
Free Cash Flow as a percentage of net income |
|
|
108 |
% |
|
|
|
|
92 |
% |
|
|
NM |
|
|
|
|
|
131 |
% |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
||||||
|
Long-term debt, net |
|
$ |
393,600 |
|
|
$ |
346,290 |
|
|
$ |
295,550 |
|
|
Less: Cash and cash equivalents |
|
|
136,960 |
|
|
|
73,950 |
|
|
|
99,740 |
|
|
Net Debt |
|
$ |
256,640 |
|
|
$ |
272,340 |
|
|
$ |
195,810 |
|
Appendix I
|
|
||||||||
|
Reconciliation of GAAP to Non-GAAP Financial Measures |
||||||||
|
Forecasted Diluted Earnings Per Share Guidance |
||||||||
|
(Unaudited - dollars per share) |
||||||||
|
|
|
Twelve months ended |
||||||
|
|
|
|
||||||
|
|
|
Low |
|
High |
||||
|
Diluted earnings per share (GAAP) |
|
$ |
1.44 |
|
|
$ |
1.53 |
|
|
Pre-tax amortization of acquisition-related intangible assets(1) |
|
0.49 |
|
|
0.49 |
|
||
|
Income tax benefit on amortization of acquisition-related intangible assets |
|
(0.12 |
) |
|
(0.12 |
) |
||
|
Impact of Special Items(2) |
|
0.37 |
|
|
0.37 |
|
||
|
Adjusted diluted earnings per share |
|
$ |
2.18 |
|
|
$ |
2.27 |
|
|
(1) |
These amounts relate to acquisitions completed prior to |
|
|
(2) |
The Company is unable to provide forward-looking estimates of Special Items without unreasonable effort, due to the uncertainty and inherent difficulty of predicting the occurrence and the financial impact of such items and the periods in which such items may be recognized. For the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be material to future results. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211028005301/en/
VP, Investor Relations
(248) 631-5506
sherrylauderback@trimascorp.com
Source: TriMas
